Several European countries have said they will accept a version of the AstraZeneca vaccine produced in India, known as Covishield, during border controls due to the frustration of the British who inadvertently received the vaccine, The Telegraph reported.
Such an announcement was made after it was revealed that more than five million Britons who have been given the AstraZeneca vaccine produced by the Serum Institute of India (SII) may have to follow quarantine and testing requirements when arriving in EU countries such as EU Digital. COVID certification only by those who have been vaccinated with a dose approved by the European Medicines Agency (EMA).
The vaccines, which are manufactured by the SII and approved for use by British regulators, have not been approved by the EMA and therefore do not meet current requirements to be part of the EU vaccine passport, TheSchengen.com reports.
The affected batches, which are not currently recognized by the EMA, are as follows:
4120Z001 4120Z002 4120Z003
Prime Minister Boris Johnson said, referring to the Medicines and Healthcare products Regulatory Authority (MHRA).
The Telegraph has not revealed which EU countries are allegedly accepting the Covishield vaccine as valid proof of immunity to COVID-19.
International media earlier reported that nine EU countries, along with Iceland and Switzerland, are accepting the Indian-made vaccine at their borders due to their ability to stray from the main EU scheme.
Countries include Greece and Spain, which are two of the most popular tourist destinations for Brits.
Spain has already announced that the country will learn about vaccine doses that have been manufactured in India since Covishield was listed for emergency use by the World Health Organization (WHO).
Similarly, UK nationals are exempt from entry restrictions, including testing and quarantine requirements when entering Greece, provided they have been vaccinated against the disease, have a valid negative test result, or have recovered from the virus.
As the British were so concerned about this issue, it appeared that the UK authorities were trying to get the Indian footage used in the country to get EMA approval. Regarding this, Professor Adam Finn of the Joint Committee on Immunization and Immunization said that there is no suggestion that the injection is substandard; Instead, the jab was not approved by the EMA due to
“Obviously, in the end, it is not in anyone’s interest, including the European Union, to create obstacles that do not need to be there. I expect this will be rectified in time,” Finn added.
This week, TheSchengen.com also reported that nearly 272,042 Canadians could face entry restrictions as quarantine and (dual) testing, despite the country being added to the EU’s list of epidemiologically safe third countries after it was vaccinated with Covishield.